Skip to results
Modify your search
NARROW
1-12 of 12
Authors: Pantxika Bellecave
Journal Article
Major role of dolutegravir in the emergence of the S147G integrase resistance mutation Get access
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 3, March 2025, Pages 692–696, https://doi.org/10.1093/jac/dkae457
Published: 30 December 2024
Journal Article
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey Free
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 9, September 2021, Pages 2400–2406, https://doi.org/10.1093/jac/dkab193
Published: 07 July 2021
Journal Article
EDITOR'S CHOICE
A Low Level of Darunavir Resistance–Associated Mutation Emergence in Patients With Virological Failure During Long-term Use of Darunavir in People With HIV. The ANRS CO3 Aquitaine Cohort Open Access
Open Forum Infectious Diseases, Volume 7, Issue 12, December 2020, ofaa567, https://doi.org/10.1093/ofid/ofaa567
Published: 19 November 2020
Journal Article
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients Open Access
Open Forum Infectious Diseases, Volume 6, Issue 12, December 2019, ofz500, https://doi.org/10.1093/ofid/ofz500
Published: 08 December 2019
Journal Article
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients Open Access
Open Forum Infectious Diseases, Volume 6, Issue 10, October 2019, ofz330, https://doi.org/10.1093/ofid/ofz330
Published: 12 July 2019
Journal Article
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients Free
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1368–1375, https://doi.org/10.1093/jac/dkz021
Published: 20 February 2019
Journal Article
Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen Free
Clinical Infectious Diseases, Volume 66, Issue 10, 15 May 2018, Pages 1588–1594, https://doi.org/10.1093/cid/cix1070
Published: 08 January 2018
Journal Article
High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection Free
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 9, September 2017, Pages 2681–2683, https://doi.org/10.1093/jac/dkx166
Published: 05 June 2017
Journal Article
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma Free
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 8, August 2017, Pages 2351–2354, https://doi.org/10.1093/jac/dkx128
Published: 02 May 2017
Journal Article
Virological failure of patients on maraviroc-based antiretroviral therapy Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 6, June 2015, Pages 1858–1864, https://doi.org/10.1093/jac/dkv026
Published: 19 February 2015
Journal Article
Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012–2014 Open Access
Open Forum Infectious Diseases, Volume 2, Issue 1, Winter 2015, ofv018, https://doi.org/10.1093/ofid/ofv018
Published: 01 February 2015
Journal Article
Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing Open Access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 3, March 2015, Pages 930–940, https://doi.org/10.1093/jac/dku426
Published: 21 October 2014
